Health Condition 1: K719- Toxic liver disease, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjective parameter- The patient who will agree to follow the study protocol of the informed consent letter. The patient having the following signs and symptoms for than 2 to 3 months-any of 3 symptoms 1.Agnimanda -impaired digestive power 2. Arochaka -loss of appetite 3.Ajirna-indigestion 4. Sula -pain in the abdomen 5. Adhman flatulence 6. Vitvikara -impaired bowel habit 7.Hrillas-nausea Objective parameter -any of 2 parameter Selection of the patient based on LFT Total bilirubin- greater than 1.0 mg/dl Alanine transaminase -greater than 56 IU/L Aspartate transaminase -greater than 35 IU/L Alkaline phosphatase -greater than 133 IU/L Impaired AST: ALT ratio
Exclusion criteria
Exclusion criteria: Age below 30 yrs. or above 60 yrs. Pre- existing Diabetes and other systemic disorders. History of Trauma. Pregnancy and Lactating mother. Malignancy of Liver,Hepatitis B,Cirrhosis of liver, Gilberts disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be measured based on clinical, biochemical,Haematological outcome safety and tolerability measures to determine the effectiveness and safety of the test drugs in the patients suffering from drug induced lived diseases.Timepoint: 56 days | — |
Secondary
| Measure | Time frame |
|---|---|
| The effect of the test drug medication alters the quality of life that will be evaluated after the completion of the treatment.Timepoint: 56 days | — |
Countries
India
Contacts
Institute of Post Graduate Ayurvedic Education and Research at S.V.S.P. Hospital .